Showing results (361-370 of 465) with videos related to

Sort By:
Pageof 47
Journal of Clinical Epidemiology|March 4, 2014
Developing core outcome measurement sets for clinical trials: OMERACT filter 2.0Maarten Boers, John R Kirwan, George Wells, et al.
The Journal of Rheumatology|July 3, 2015
Report from the OMERACT Hand Osteoarthritis Working Group: Set of Core Domains and Preliminary Set of Instruments for Use in Clinical Trials and Observational StudiesMargreet Kloppenburg, Pernille Bøyesen, A Willemien Visser, et al.
The Journal of Rheumatology|September 16, 2020
Reliability and Change in Erosion Measurements by High-resolution Peripheral Quantitative Computed Tomography in a Longitudinal Dataset of Rheumatoid Arthritis PatientsStephanie Finzel, Sarah L Manske, Cheryl C M Barnabe, et al.
The Lancet. Rheumatology|October 14, 2024
Efficacy and safety of a diffusion-based extended-release fluticasone propionate intra-articular injection (EP-104IAR) in knee osteoarthritis (SPRINGBOARD): a 24-week, multicentre, randomised, double-blind, vehicle-controlled, phase 2 trialAmanda Malone, Mark M Kowalski, James Helliwell, et al.
The Journal of Rheumatology|May 17, 2019
Developing a Preliminary Definition and Domains of Flare in Knee and Hip Osteoarthritis (OA): Consensus Building of the Flare-in-OA OMERACT GroupFrancis Guillemin, Camille Ricatte, Annica Barcenilla-Wong, et al.
Rheumatology (Oxford, England)|August 25, 2014
Inadequate pain relief and large functional loss among patients with knee osteoarthritis: evidence from a prospective multinational longitudinal study of osteoarthritis real-world therapiesPhilip G Conaghan, Paul M Peloso, Sharlette V Everett, et al.
RMD Open|September 27, 2017
Scoring ultrasound synovitis in rheumatoid arthritis: a EULAR-OMERACT ultrasound taskforce-Part 1: definition and development of a standardised, consensus-based scoring systemMaria-Antonietta D'Agostino, Lene Terslev, Philippe Aegerter, et al.
Lancet (London, England)|July 3, 2015
Secukinumab, a human anti-interleukin-17A monoclonal antibody, in patients with psoriatic arthritis (FUTURE 2): a randomised, double-blind, placebo-controlled, phase 3 trialIain B McInnes, Philip J Mease, Bruce Kirkham, et al.
Rheumatology (Oxford, England)|September 18, 2016
Improvement in insulin resistance is greater when infliximab is added to methotrexate during intensive treatment of early rheumatoid arthritis-results from the IDEA studyLesley-Anne Bissell, Elizabeth M A Hensor, Lukasz Kozera, et al.
The Lancet. Rheumatology|January 27, 2024
MRI of the joint and evaluation of the granulocyte-macrophage colony-stimulating factor-CCL17 axis in patients with rheumatoid arthritis receiving otilimab: a phase 2a randomised mechanistic studyMark C Genovese, Mario Berkowitz, Philip G Conaghan, et al.
Pageof 47